The function of Golgi apparatus in LRRK2-associated Parkinson's disease

被引:4
|
作者
Wei, Yonghang [1 ]
Awan, Maher un Nisa [1 ]
Bai, Liping [1 ]
Bai, Jie [1 ]
机构
[1] Kunming Univ Sci & Technol, Med Sch, Lab Mol Neurobiol, Kunming, Peoples R China
来源
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2023年 / 16卷
基金
中国国家自然科学基金;
关键词
Parkinson's; LRRK2; Rab29; VPS52; PKC; Golgi apparatus; ANIMAL-MODELS; LRRK2; KINASE; FRAGMENTATION; PROTEINS; PHOSPHORYLATION; TRAFFICKING; RAB; MUTATIONS; TRANSPORT;
D O I
10.3389/fnmol.2023.1097633
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a chronic neurodegenerative disease associated with the intracellular organelles. Leucine-rich repeat kinase 2 (LRRK2) is a large multi-structural domain protein, and mutation in LRRK2 is associated with PD. LRRK2 regulates intracellular vesicle transport and function of organelles, including Golgi and lysosome. LRRK2 phosphorylates a group of Rab GTPases, including Rab29, Rab8, and Rab10. Rab29 acts in a common pathway with LRRK2. Rab29 has been shown to recruit LRRK2 to the Golgi complex (GC) to stimulate LRRK2 activity and alter the Golgi apparatus (GA). Interaction between LRRK2 and Vacuolar protein sorting protein 52 (VPS52), a subunit of the Golgi-associated retrograde protein (GARP) complex, mediates the function of intracellular soma trans-Golgi network (TGN) transport. VPS52 also interacts with Rab29. Knockdown of VPS52 leads to the loss of LRRK2/Rab29 transported to the TGN. Rab29, LRRK2, and VPS52 work together to regulate functions of the GA, which is associated with PD. We highlight recent advances in the roles of LRRK2, Rabs, VPS52, and other molecules, such as Cyclin-dependent kinase 5 (CDK5) and protein kinase C (PKC) in the GA, and discuss their possible association with the pathological mechanisms of PD.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2
    Biosa, Alice
    Trancikova, Alzbeta
    Civiero, Laura
    Glauser, Liliane
    Bubacco, Luigi
    Greggio, Elisa
    Moore, Darren J.
    HUMAN MOLECULAR GENETICS, 2013, 22 (06) : 1140 - 1156
  • [42] Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson's Disease
    Rosenbusch, Katharina E.
    Kortholt, Arjan
    PARKINSONS DISEASE, 2016, 2016
  • [43] Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's disease
    Podlesniy, Petar
    Puigros, Margalida
    Serra, Nuria
    Fernandez-Santiago, Ruben
    Ezquerra, Mario
    Tolosa, Eduardo
    Trullas, Ramon
    EBIOMEDICINE, 2019, 48 : 554 - 567
  • [44] Protein synthesis is suppressed in sporadic and familial Parkinson's disease by LRRK2
    Deshpande, Prasannakumar
    Flinkman, Dani
    Hong, Ye
    Goltseva, Elena
    Siino, Valentina
    Sun, Lihua
    Peltonen, Sirkku
    Elo, Laura L.
    Kaasinen, Valtteri
    James, Peter
    Coffey, Eleanor T.
    FASEB JOURNAL, 2020, 34 (11) : 14217 - 14233
  • [45] Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease
    Karayel, Oezge
    Tonelli, Francesca
    Virreira Winter, Sebastian
    Geyer, Phillip E.
    Fan, Ying
    Sammler, Esther M.
    Alessi, Dario R.
    Steger, Martin
    Mann, Matthias
    MOLECULAR & CELLULAR PROTEOMICS, 2020, 19 (09) : 1546 - 1560
  • [46] The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson's Disease
    Rideout, Hardy J.
    Chartier-Harlin, Marie-Christine
    Fell, Matthew J.
    Hirst, Warren D.
    Huntwork-Rodriguez, Sarah
    Leyns, Cheryl E. G.
    Mabrouk, Omar S.
    Taymans, Jean-Marc
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [47] Cognitive Profile of LRRK2-Related Parkinson's Disease
    Srivatsal, Sindhu
    Cholerton, Brenna
    Leverenz, James B.
    Wszolek, Zbigniew K.
    Uitti, Ryan J.
    Dickson, Dennis W.
    Weintraub, Daniel
    Trojanowski, John Q.
    Van Deerlin, Vivianna M.
    Quinn, Joseph F.
    Chung, Kathryn A.
    Peterson, Amie L.
    Factor, Stewart A.
    Wood-Siverio, Cathy
    Goldman, Jennifer G.
    Stebbins, Glenn T.
    Bernard, Bryan
    Ritz, Beate
    Rausch, Rebecca
    Espay, Alberto J.
    Revilla, Fredy J.
    Devoto, Johnna
    Rosenthal, Liana S.
    Dawson, Ted M.
    Albert, Marilyn S.
    Mata, Ignacio F.
    Hu, Shu-Ching
    Montine, Kathleen S.
    Johnson, Catherine
    Montine, Thomas J.
    Edwards, Karen L.
    Zhang, Jing
    Zabetian, Cyrus P.
    MOVEMENT DISORDERS, 2015, 30 (05) : 728 - 733
  • [48] Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2
    Belluzzi, Elisa
    Greggio, Elisa
    Piccoli, Giovanni
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1111 - 1116
  • [49] Development of LRRK2 Kinase Inhibitors for Parkinson's Disease
    Galatsis, Paul
    Henderson, Jaclyn
    Kormos, Bethany L.
    Hirst, Warren D.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 43 - 58
  • [50] Structural basis for Parkinson's disease-linked LRRK2's binding to microtubules
    Snead, David M.
    Matyszewski, Mariusz
    Dickey, Andrea M.
    Lin, Yu Xuan
    Leschziner, Andres E.
    Reck-Peterson, Samara L.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2022, 29 (12) : 1196 - +